Please Follow us on Gab, Minds, Telegram, Rumble, Gettr, Truth Social, Twitter
Hot off the presses, Senate Joint Resolution No. 4, introduced by the Government Administration and Elections Committee, proposes an amendment to the equal protection clause in the Connecticut State Constitution "concerning discrimination on the basis of sex" that redefines the word "sex".
Specifically, the proposed language states:
As used in this section, discrimination in the exercise or enjoyment of civil or political rights because of sex includes, but is not limited to, discrimination, in intent or effect, based on pregnancy, including preventing, initiating, continuing or terminating a pregnancy; sexual orientation; gender identity and expression; and related health care.
Adding abortion to the equal protection clause would likely make it nearly impossible to put any kind of legal limits on abortion, unless there is a health concern.
Similarly, the equal protection clause would be extended to gender identity and expression, including "related health care" at a time when gender-affirming care is being banned not just in other states, but in other countries, including most recently the United Kingdom.
In fact, the UK's National Health Service (NHS) just posted the following on March 12, 2024:
Puberty blockers (gonadotrophin-releasing hormone analogues) are not available to children and young people for gender incongruence or gender dysphoria because there is not enough evidence of safety and clinical effectiveness.
NHS Gender Dysphoria Treatment Guidelines
NHS admitted that hormones cause irreversible changes related to breast development (caused by taking estrogen) and breaking or deepening of the voice (caused by taking testosterone). It further states that long-term cross-sex hormone treatment may cause temporary or even permanent infertility, and that there is uncertainty surrounding the long-term risks from cross-sex hormone treatment.
Children, young people and their families are also being discouraged by NHS from obtaining puberty blockers or gender affirming hormones from unregulated sources or online providers that are not regulated by UK regulatory bodies, either.
Moreover, the recently released World Professional Association for Transgender Health (WPATH) files have revealed that gender medicine is "neither science nor medicine".
The files, released through Environmental Progress by a whistleblower, show that WPATH members are well aware of the debilitating and potentially fatal side effects of cross-sex hormones and other treatments, and worse, that they do not appear to be concerned with long-term patient outcomes.
One exchange contained in the files reveals a physician-assistant and professor at Yale School of Medicine who posted in a WPATH group, asking for "advice about a developmentally delayed 13-year-old who was already on puberty blockers but may not reach the 'emotional and cognitive developmental bar set by [the WPATH SOC8 guidelines] within the typical adolescent time frame if at all' to give cognitive consent to cross-sex hormones."
The Yale professor and practicing clinician wanted to know when it would be ethical to allow the young patient to progress to “gender affirming hormone therapy.”
More and more medical and psychiatric professionals agree that the promotion of gender-affirming care involving hormones and/or surgery will eventually be recognized as a global medical scandal on par with historical incidents of medical malpractice, like lobotomies and ovariotomies.
But in Connecticut, if this resolution were to pass, one has to wonder whether disagreement over gender identity lessons in the classroom or who can play on a girl's sports team could be viewed as discriminatory behavior, and potentially subject to criminal and civil charges.
The Government Administration and Elections Committee will hold a public hearing on this resolution this Monday, March 18, 2024, at 11:30 A.M. in Room 2B of the Legislative Office Building and via Zoom.
You can sign up to deliver oral testimony by clicking here. The speaker registration deadline is Sunday, March 17, 2024, at 3:00 PM.
You can submit online testimony by clicking here. Note that you have to choose March 18th for the hearing date, and then select SJ00004 from the "bill" drop-down box.
